)
Duane Nash
CEO
Gliomic Therapeutics
Chief executive officer of Gliomic, Inc. Fifteen years of leadership experience in executive, CEO, chairman and board roles in both public and private companies. Has successfully grown / led drug development public and private companies, including IPO process, and served as finance lead on IPO and multiple private and public rounds $1B+. California- licensed physician with clinical training at UCSF in general surgery. Member of California Legal Bar with 6 years big firm experience and focus on both intellectual property and corporate governance. Eight years of experience in developing DHODH inhibitor drugs, and served as former Chairman of Gliomic's parent company, Immunic, which specifically created Gliomic to allow Immunic to retain its focus on auto-immune disease. Transitioned to full-time Gliomic role to assist in development of this very exciting asset, with a remarkably differentiated target product profile, and intended to serve a true unmet need in genetically-defined populations of brain cancer.
Sessions
-
22-Jun-2026Theater 2Gliomic Therapeutics
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}